Director Shareholding
December 10 2001 - 12:22PM
UK Regulatory
RNS Number:4661O
Cambridge Antibody Tech Group PLC
10 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
David Chiswell
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
(i) As in 2 above
(ii) As in 2 above
(iii) As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
(i) Linda Chiswell (spouse)
(ii) David Chiswell
(iii) Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
(i) Spouse
(ii) As in 2 above
(III) As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
(i) Sale of 34,484 shares
(ii) The purchase of 66 shares pursuant to the Cambridge Antibody Technology
Inland Revenue approved All Employee Share Ownership Plan
(iii) The grant of 66 "Free" matching shares pursuant to the Cambridge
Antibody Technology Inland Revenue approved All Employee Share Ownership Plan
7) Number of shares/amount of
stock acquired
(i) Nil
(ii) 66 shares
(iii) 66 shares
8) Percentage of issued class
(i) Nil
(ii) 0.0002%
(iii) 0.0002%
9) Number of shares/amount
of stock disposed
(i) 34,484
(ii) Nil
(iii) Nil
10) Percentage of issued class
(i) 0.097%
(ii) Nil
(iii) Nil
11) Class of security
Ordinary 10p shares
12) Price per share
(i) 1702p
(ii) 1692p
(iii) 1692p
13) Date of transaction
7 December 2001
14) Date company informed
10 December 2001
15) Total holding following this notification
441,865
16) Total percentage holding of issued class following this notification
1.244%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 10 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
John Aston
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
(i) As in 2 above
(ii) As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
(i) John Aston
(ii) Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
(i) The purchase of 66 shares pursuant to the Cambridge Antibody Technology
Inland Revenue approved All Employee Share Ownership Plan.
(ii) The grant of 66 "Free" matching shares pursuant to the Cambridge Antibody
Technology Inland Revenue approved All Employee Share Ownership Plan
7) Number of shares/amount of stock acquired
(i) 66 shares
(ii) 66 shares
8) Percentage of issued class
(i) 0.0002%
(ii) 0.0002%
9) Number of shares/amount of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
Ordinary 10p shares
12) Price per share
#16.92
13) Date of transaction
7 December 2001
14) Date company informed
10 December 2001
15) Total holding following this notification
10,666
16) Total percentage holding of issued class following this notification
0.030%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 10 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
David Glover
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
(i) As in 2 above
(ii) As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
(i) David Glover
(ii) Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
As in 2 above
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
(i) The purchase of 66 shares pursuant to the Cambridge Antibody Technology
Inland Revenue approved All Employee Share Ownership Plan
(ii) The grant of 66 "Free" matching shares pursuant to the Cambridge Antibody
Technology Inland Revenue approved All Employee Share Ownership Plan
7) Number of shares/amount of stock acquired
(i) 66 shares
(ii) 66 shares
8) Percentage of issued class
(i) 0.0002%
(ii) 0.0002%
9) Number of shares/amount of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
Ordinary 10p shares
12) Price per share
#16.92
13) Date of transaction
7 December 2001
14) Date company informed
10 December 2001
15) Total holding following this notification
12,857
16) Total percentage holding of issued class following this notification
0.036%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of Notification 10 December 2001
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
